Skip to main content

Greenberg Traurig’s Nancy Taylor to Speak on Food and Drug Law Institute’s Live Webinar

WASHINGTON, D.C. – Jan. 24, 2023 Nancy E. Taylor, co-chair of the Health Care & FDA Practice of global law firm Greenberg Traurig, LLP, will speak on the Food and Drug Law Institute’s (FDLI) Live Webinar Jan. 25 from 2:00-3:30 p.m.

The panel, titled “Implementation of the Inflation Reduction Act: Healthcare Reform and Implications for the Pharmaceutical Industry,” will discuss “the multi-faceted implications of the IRA on industry and the state of public health, as well as benefits and risks posed by implementing this framework, including impacts on prescription drug affordability, generic drugs, orphan drug exclusivity, differential treatment between small molecules and biologics, and strategy shifting for industry,” according to FDLI.

Taylor focuses her practice on health and FDA related matters. She has broad experience working with providers, plans, employers, private equity firms, and FDA regulated companies. She advises clients on health care transactions, health and FDA regulatory policy and compliance, and responding to Congressional and Administration investigations and audits. Prior to joining Greenberg Traurig, Taylor served 10 years as health policy director for a Senate committee and worked on numerous significant health and FDA laws. She also served as CEO of a startup medical device company, where she obtained eight product clearances, including securing reimbursement coverage for each product.

About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing health care marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2500 attorneys in 43 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm reported gross revenue of over $2 Billion for FY 2021 and is consistently among the top firms on the Am Law 100, Am Law Global 100, and NLJ 250. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 5.0 Certified Plus by The Diversity Lab and the Center for Resource Solutions Green-e® Energy program certifies that the firm’s U.S. offices are 100% powered by renewable energy. The firm is often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono. Web: